FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases

FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases

Submitted by admin on November 2, 2022 - 10:18am
Source: 
Fierce Pharma
News Tags: 
Pfizer
Paxlovid
antivirals
COVID-19
FDA
Robert Califf
Headline: 
FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases
snippet: 

Amid high-profile reports of "rebound" cases in people who received Pfizer's COVID-19 oral antiviral, Paxlovid, FDA commissioner Robert Califf is standing behind the agency's rationale in granting its authorization.

Do Not Allow Advertisers to Use My Personal information